ZAYGEO Trademark

Trademark Overview


On Wednesday, August 26, 2020, a trademark application was filed for ZAYGEO with the United States Patent and Trademark Office. The USPTO has given the ZAYGEO trademark a serial number of 79295699. The federal status of this trademark filing is REGISTERED as of Tuesday, August 31, 2021. This trademark is owned by LABORATORIOS FARMACEUTICOS ROVI, S.A.. The ZAYGEO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, antibiotics, analgesics, anaesthetics, amino acids for medical use, antiseptics, tranquilizers, collyriums, digestives for pharmaceutical purposes, laxatives, and prescription synthetic narcotics; Chemical preparations for medical use, being pharmaceuticals for treating schizophrenia; chemical pharmaceuticals preparations for the treatment of diseases of the central nervous system; tonics being medicines for the treatment of headaches; tranquillizers; soporifics; Pharmaceutical preparations, namely, antipsychotics; medicated serums for the treatment of eczema; hormones; oral contraceptives; vaccines; syringes, vials, cartridges, carpules and ampoules for medical purposes sold filled with pharmaceutical preparations in the nature of antipsychotics; pharmaceutical implants for delivering insulin, namely, implantable subcutaneous drug delivery devices sold filled with insulin; sustained release medicine implants for delivering contraceptives, namely, i...
zaygeo

General Information


Serial Number79295699
Word MarkZAYGEO
Filing DateWednesday, August 26, 2020
Status700 - REGISTERED
Status DateTuesday, August 31, 2021
Registration Number6465784
Registration DateTuesday, August 31, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 15, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, antibiotics, analgesics, anaesthetics, amino acids for medical use, antiseptics, tranquilizers, collyriums, digestives for pharmaceutical purposes, laxatives, and prescription synthetic narcotics; Chemical preparations for medical use, being pharmaceuticals for treating schizophrenia; chemical pharmaceuticals preparations for the treatment of diseases of the central nervous system; tonics being medicines for the treatment of headaches; tranquillizers; soporifics; Pharmaceutical preparations, namely, antipsychotics; medicated serums for the treatment of eczema; hormones; oral contraceptives; vaccines; syringes, vials, cartridges, carpules and ampoules for medical purposes sold filled with pharmaceutical preparations in the nature of antipsychotics; pharmaceutical implants for delivering insulin, namely, implantable subcutaneous drug delivery devices sold filled with insulin; sustained release medicine implants for delivering contraceptives, namely, implantable subcutaneous sustained release drug delivery devices sold filled with contraceptives; oncological preparations being pharmaceuticals for the treatment of cancer; Pharmaceutical preparations for the treatment of diseases of the central nervous system; Pharmaceutical preparations for the treatment of schizophrenia; Pharmaceutical preparations for the treatment of hormonal disorders; Pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for the treatment of damaged skin, thrombosis, coagulation diseases, infections, flu, pain and inflammation; Tranquilizers; prescription synthetic narcotics; antidepressants; anxiolytics being pharmaceutical preparations for the treatment of anxiety; disposable syringes sold pre-filled with pharmaceutical preparations for treatment of central nervous system diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 20, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLABORATORIOS FARMACEUTICOS ROVI, S.A.
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressES

Party NameLABORATORIOS FARMACEUTICOS ROVI, S.A.
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressES

Party NameLABORATORIOS FARMACEUTICOS ROVI, S.A.
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressES

Trademark Events


Event DateEvent Description
Friday, February 2, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, February 2, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 2, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 2, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, March 26, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, February 11, 2022GENERIC MADRID TRANSACTION SENT TO IB
Friday, February 11, 2022GENERIC MADRID TRANSACTION CREATED
Tuesday, November 30, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 31, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, June 15, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 15, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 7, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 5, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 4, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 4, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, February 6, 2021REFUSAL PROCESSED BY IB
Tuesday, January 19, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, January 19, 2021REFUSAL PROCESSED BY MPU
Wednesday, December 30, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, December 29, 2020NON-FINAL ACTION WRITTEN
Sunday, December 27, 2020ASSIGNED TO EXAMINER
Saturday, October 24, 2020APPLICATION FILING RECEIPT MAILED
Tuesday, October 20, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 19, 2020LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, October 15, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB